We are live on ! Find out more
RDHL

Redhill Biopharma

17 hedge funds and large institutions have $514K invested in Redhill Biopharma in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

905% more capital invested

Capital invested by funds: $51.2K → $514K (+$463K)

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

21% more funds holding

Funds holding: 1417 (+3)

14.29% more ownership

Funds ownership: 0.71%15% (+14%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

RDHL Hedge Fund Activity: Q4 2025 in Review

17 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2025, worth a combined $514K — up 905% from $51.2K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new RDHL positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Yorkville Advisors Global, opening a new position worth an estimated $520K. The largest seller was SBI Securities, cutting an estimated $71.

  • 17 institutional investors held Redhill Biopharma (RDHL) as of Q4 2025, up from 14 in Q3 2025.
  • Funds reported $514K of Redhill Biopharma stock for Q4 2025, up 905% quarter-over-quarter.
  • 4 funds opened new Redhill Biopharma positions in Q4 2025 and 1 closed out, a net change of +3 holders.
  • The largest Redhill Biopharma buyer in Q4 2025 was Yorkville Advisors Global, an estimated $520K added.
  • The largest Redhill Biopharma seller in Q4 2025 was SBI Securities, an estimated $71 sold.

Based on aggregated 13F filings for Q4 2025.